
The authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.
The authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.
Published: September 1st 2009 | Updated: